NRF-1 Regulates CD47 Expression in Melanoma
Author Information
Author(s): Makwana Kuldeep, Velazquez Edwin J., Marzese Diego M., Smith Bethany, Bhowmick Neil A., Faries Mark B., Hamid Omid, Boiko Alexander D.
Primary Institution: Cedars-Sinai Medical Center
Hypothesis
The study investigates the role of NRF-1 transcription factor in regulating CD47 expression during melanomagenesis.
Conclusion
The study found that NRF-1 is a key regulator of CD47 expression in melanoma, influencing immune evasion.
Supporting Evidence
- CD47 is upregulated in melanoma and inhibits anti-tumor immune responses.
- NRF-1 binds to the CD47 promoter, enhancing its expression.
- High levels of CD47 are associated with poor prognosis in melanoma patients.
- Downregulation of NRF-1 significantly reduces CD47 expression.
- Chromatin accessibility at the CD47 promoter is increased in melanoma cells.
Takeaway
This study shows that a protein called NRF-1 helps cancer cells make a signal that tells the immune system to leave them alone, which can make the cancer grow.
Methodology
The study used ATAC-sequencing, qRT-PCR, and ChIP assays to analyze CD47 expression and its regulation by NRF-1 in melanoma cells.
Potential Biases
Potential bias in the selection of melanoma samples and the interpretation of data from various datasets.
Limitations
The study primarily focuses on melanoma and may not be generalizable to other cancer types.
Participant Demographics
The study analyzed data from 422 melanoma patients and 123 normal skin subjects.
Statistical Information
P-Value
0.0149
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website